Grace Therapeutics, Inc. - Common Stock (ACST)
CUSIP: 00430K865
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 16,612,245
- Total 13F shares
- 2,152,387
- Share change
- +886,955
- Total reported value
- $6,299,610
- Price per share
- $2.93
- Number of holders
- 12
- Value change
- +$2,590,846
- Number of buys
- 7
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 00430K865?
CUSIP 00430K865 identifies ACST - Grace Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00430K865:
Top shareholders of ACST - Grace Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AIGH Capital Management LLC |
13F
|
Company |
3%
|
497,359
|
$1,706,549 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
3%
|
494,698
|
$1,694,341 | — | 31 Mar 2024 | |
| ADAR1 Capital Management, LLC |
13F
3/4/5
|
Company · 10%+ Owner |
1.3%
|
217,381
|
$744,530 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.22%
|
36,650
|
$126,443 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.08%
|
12,584
|
$43,000 | — | 31 Mar 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.02%
|
2,901
|
$7,974 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,947
|
$6,668 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
1,882
|
$6,445 | — | 31 Mar 2024 | |
| Donald Olds |
3/4/5
|
Director |
—
class O/S missing
|
1,173
|
$2,168 | — | 31 Aug 2023 | |
| NBC SECURITIES, INC. |
13F
|
Company |
0%
|
2
|
$1,000 | — | 31 Mar 2024 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
28
|
$96 | — | 31 Mar 2024 | |
| Rajitha Grace 2018 Irrevocable Trust |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
4,689,547
|
— | — | 27 Aug 2021 | |
| Janelle D'Alvise |
3/4/5
|
PRESIDENT & CEO, Director |
—
class O/S missing
|
560,000
|
— | — | 22 Jun 2022 | |
| Brian D. Ford |
3/4/5
|
CHIEF FINANCIAL OFFICER |
—
class O/S missing
|
165,000
|
— | — | 22 Jun 2022 | |
| Pierre Lemieux |
3/4/5
|
COO, Canada & CSO |
—
class O/S missing
|
165,000
|
— | — | 22 Jun 2022 | |
| John Canan |
3/4/5
|
Director |
—
class O/S missing
|
45,000
|
— | — | 28 Sep 2022 | |
| Roderick Noel Carter |
3/4/5
|
Director |
—
class O/S missing
|
42,100
|
— | — | 12 Nov 2021 | |
| William A. Haseltine |
3/4/5
|
Director |
—
class O/S missing
|
42,100
|
— | — | 12 Nov 2021 | |
| Michael Derby |
3/4/5
|
Director |
—
class O/S missing
|
12,500
|
— | — | 14 Jul 2023 |
Institutional Holders of Grace Therapeutics, Inc. - Common Stock (ACST) as of Q2 2024
As of 30 Jun 2024,
Grace Therapeutics, Inc. - Common Stock (ACST) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,152,387 shares.
The largest 10 holders included
ADAR1 Capital Management, LLC, AIGH Capital Management LLC, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, Royal Bank of Canada, NATIONAL BANK OF CANADA /FI/, MORGAN STANLEY, Activest Wealth Management, and Federation des caisses Desjardins du Quebec.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
10
Q2 2024 holders
12
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.